Older Cancer Patients
Conditions
Brief summary
The aim of this study is to validate uHear™, an iOS-based tool, as a screening tool to detect significant hearing impairment as part of a comprehensive geriatric assessment in patients aged 70 years and older. The pass or fail screening cut-off is defined as having two or more consecutive hearing grades starting from the moderate-severe threshold zone ranging from 0.5 - 2.0 kHz.
Interventions
None listed
Sponsors
General Hospital Groeninge
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients should have reached the age of 70 or more at enrolment * Histologically confirmed diagnosis of solid cancer or hematologic malignancy. All stages of cancer are eligible * Patients should be fluent in Dutch or French * Patients must receive their primary oncology care in the participating hospital * Patients should be cognitively capable of performing the audiology assessment * Patients should be scheduled to receive a CGA * Patients should have signed informed consent
Exclusion criteria
* Patients who do not match the above inclusion criteria * Patients presenting with clinically diagnosed Meniere's disease, retrocochlear hearing loss, autoimmune inner ear disease, fluctuating hearing loss or a history of sudden sensory neural hearing loss * Patients who already have a hearing aid or a previously diagnosed hearing loss
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Validation of uHear™ with its new scoring method as a screening tool to detect hearing loss in older cancer patients | baseline |
Countries
Belgium
Outcome results
None listed